Hypha Labs, Inc.
FUNI
$0.0263
-$0.0017-6.07%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 619.20K | 1.31M | 502.80K | 613.60K | 574.00K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 619.20K | 1.31M | 502.80K | 613.60K | 574.00K |
Operating Income | -619.20K | -1.31M | -502.80K | -613.60K | -574.00K |
Income Before Tax | -641.80K | -1.34M | -477.80K | -729.60K | -8.00K |
Income Tax Expenses | -- | -- | -11.80K | -22.70K | 48.70K |
Earnings from Continuing Operations | -641.80K | -1.34M | -466.00K | -706.90K | -56.70K |
Earnings from Discontinued Operations | -- | -- | 0.00 | -- | 292.50K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -641.80K | -1.34M | -466.00K | -706.90K | 235.80K |
EBIT | -619.20K | -1.31M | -502.80K | -613.60K | -574.00K |
EBITDA | -617.30K | -1.30M | -501.90K | -613.50K | -- |
EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 |
Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 131.08M | 124.62M | 118.58M | 107.73M | 92.08M |
Average Diluted Shares Outstanding | 131.08M | 124.62M | 118.58M | 107.73M | 92.08M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |